Uli Hacksell

7.3k total citations · 2 hit papers
193 papers, 5.9k citations indexed

About

Uli Hacksell is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Uli Hacksell has authored 193 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Molecular Biology, 79 papers in Organic Chemistry and 70 papers in Cellular and Molecular Neuroscience. Recurrent topics in Uli Hacksell's work include Receptor Mechanisms and Signaling (63 papers), Neurotransmitter Receptor Influence on Behavior (41 papers) and Pharmacological Receptor Mechanisms and Effects (25 papers). Uli Hacksell is often cited by papers focused on Receptor Mechanisms and Signaling (63 papers), Neurotransmitter Receptor Influence on Behavior (41 papers) and Pharmacological Receptor Mechanisms and Effects (25 papers). Uli Hacksell collaborates with scholars based in Sweden, United States and Netherlands. Uli Hacksell's co-authors include Jonas Nilsson, Arvid Carlsson, Stephan Hjorth, Per Lindberg, G. Doyle Daves, L. -E. Arvidsson, Domènec J. Sánchez, Kristina Luthman, Anette M. Johansson and Mark R. Brann and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Uli Hacksell

189 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

8-hydroxy-2-(di-n-propylamino)tetralin, 8-OH-DPAT, a potent and selective simplified ergot congener with central 5-HT-receptor stimulating activity

1982 472 citations Stephan Hjorth, Arvid Carlsson et al. Journal of Neural Transmission profile →
Effects of a new type of 5-HT receptor agonist on male rat sexual behavior

1981 262 citations Stephan Hjorth, Arvid Carlsson et al. profile →

Peers

Countries citing papers authored by Uli Hacksell

Since Specialization

Citations

This map shows the geographic impact of Uli Hacksell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uli Hacksell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uli Hacksell more than expected).

Fields of papers citing papers by Uli Hacksell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uli Hacksell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uli Hacksell. The network helps show where Uli Hacksell may publish in the future.

Co-authorship network of co-authors of Uli Hacksell

This figure shows the co-authorship network connecting the top 25 collaborators of Uli Hacksell. A scholar is included among the top collaborators of Uli Hacksell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uli Hacksell. Uli Hacksell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	II. In vitro evidence that (−)-OSU6162 and (+)-OSU6162 produce their behavioral effects through 5-HT2A serotonin and D2 dopamine receptors 2011 ·Journal of Neural Transmission ·Ethan S. Burstein, Maria Carlsson, (unknown), Jian‐Nong Ma, Hans H. Schiffer, Arvid Carlsson, Uli Hacksell	28
2	Novel and potent small-molecule urotensin II receptor agonists 2009 ·Bioorganic & Medicinal Chemistry ·Fredrik Lehmann, Erika A. Currier, Bryan Clemons, Lars Kristian Hansen, Roger Olsson, Uli Hacksell, Kristina Luthman	6
3	Constitutively Active Mutants of the Histamine H1 Receptor Suggest a Conserved Hydrophobic Asparagine-Cage That Constrains the Activation of Class A G Protein-Coupled Receptors 2007 ·Molecular Pharmacology ·Remko A. Bakker, Aldo Jongejan, Kamonchanok Sansuk, Uli Hacksell, Henk Timmerman, Mark R. Brann, (unknown), Leonardo Pardo, Rob Leurs	23
4	8R-Lisuride Is a Potent Stereospecific Histamine H1-Receptor Partial Agonist 2004 ·Molecular Pharmacology ·Remko A. Bakker, (unknown), Antonius ter Laak, Thijs Beuming, Obbe P. Zuiderveld, (unknown), Uli Hacksell, H. Timmerman, Mark R. Brann, Rob Leurs	24
5	Pharmacological Characterization of AC-90179 [2-(4-Methoxyphenyl)-N-(4-methyl-benzyl)-N-(1-methyl-piperidin-4-yl)-acetamide Hydrochloride]: A Selective Serotonin 2A Receptor Inverse Agonist 2004 ·Journal of Pharmacology and Experimental Therapeutics ·Kimberly E. Vanover, Scott C. Harvey, Thomas Son, Stefania Risso Bradley, (unknown), Malath Makhay, Isaac Veinbergs, Tracy A. Spalding, David M. Weiner, Carl Magnus Andersson, Bo‐Ragnar Tolf, Mark R. Brann, Uli Hacksell, Robert E. Davis	18
6	Analysis of molecular determinants of affinity and relative efficacy of a series of R‐ and S‐2‐(dipropylamino)tetralins at the 5‐HT_1A serotonin receptor 2003 ·British Journal of Pharmacology ·Janet Alder, Uli Hacksell, Philip G. Strange	5
7	Discovery of an Ectopic Activation Site on the M₁Muscarinic Receptor 2002 ·Molecular Pharmacology ·Tracy A. Spalding, Carol Trotter, Niels Skjærbæk, Terri Messier, Erika A. Currier, Ethan S. Burstein, Donghui Li, Uli Hacksell, Mark R. Brann	156
8	Chemical genomics: massively parallel technologies for rapid lead identification and target validation 2002 ·Cytotechnology ·Uli Hacksell, Norman Nash, Ethan S. Burstein, Fabrice Piu, Glenn Croston, Mark R. Brann	4
9	Investigating mechanisms of agonist action at the human D-2short dopamine receptor 1999 ·British Journal of Pharmacology ·(unknown), (unknown), (unknown), Uli Hacksell	1
10	Chapter 11 3-Heteroarylquinuclidin-2-ene derivatives as muscarinic antagonists: synthesis, structure-activity relationships and molecular modelling 1996 ·Progress in brain research ·Gunnar Nordvall, Björn M. Nilsson, (unknown), Gary Johansson, (unknown), Lisbeth Nilvebrant, Uli Hacksell	7
11	Does the Dopamine Receptor Subtype Selectivity of Antipsychotic Agents Provide Useful Leads for the Development of Novel Therapeutic Agents? 1995 ·Pharmacology & Toxicology ·Uli Hacksell, David M. Jackson, Nina Mohell	9
12	Synthesis of (+)‐(R)‐ and (−)‐(S)‐5‐hydroxy‐2‐methyl‐2‐dipropylaminotetralin: Effects on rat hippocampal output of 5‐HT, 5‐HIAA, and DOPAC as determined by in vivo microdialysis 1993 ·Chirality ·(unknown), Anette M. Johansson, Stephan Hjorth, Staffan Sundell, Uli Hacksell	3
13	Derivatives of 2-(dipropylamino)tetralin: effect of the C8-substituent on the interaction with 5-HT1A receptors 1993 ·Journal of Medicinal Chemistry ·Ye Liu, Hong Yu, Birte Svensson, (unknown), Tommy Lewander, Uli Hacksell	25
14	Effects of (R)-8-OH-DPAT and the enantiomers of UH-301 on motor activities in the rat: antagonism of (R)-8-OH-DPAT-induced effects 1992 ·European Neuropsychopharmacology ·(unknown), Anders Fredriksson, Uli Hacksell, Tommy Lewander	25
15	Synthesis and pharmacology of the enantiomers of cis-7-hydroxy-3-methyl-2-(dipropylamino)tetralin 1990 ·Journal of Medicinal Chemistry ·Anna‐Karin Johansson, Karin Fredriksson, Uli Hacksell, Cor J. Grol, Kjell Svensson, Anna‐Carin C. Carlsson, S. Sundell	9
16	Resolved N,N-dialkylated 2-amino-8-hydroxytetralins: stereoselective interactions with 5-HT1A receptors in the brain 1989 ·Journal of Medicinal Chemistry ·(unknown), (unknown), D L Nelson, N.‐E. Andén, Uli Hacksell	51
17	Topography and conformational preferences of 6,7,8,9-tetrahydro-1-hydroxy-N,N-dipropyl-5H-benzocyclohepten-6-ylamine. A rationale for the dopaminergic inactivity 1989 ·Journal of Medicinal Chemistry ·Anders Karlén, (unknown), (unknown), Uli Hacksell	3
18	Central dopaminergic and 5-hydroxytryptaminergic effects of C(3)-methylated derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin 1988 ·Journal of Medicinal Chemistry ·Charlotta Mellin, (unknown), Anders Karlén, Anette M. Johansson, Staffan Sundell, (unknown), David L. Nelson, (unknown), Uli Hacksell	15
19	Effects of the C3-methylated derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on central 5-hydroxytryptamine receptors 1987 ·European Journal of Pharmacology ·(unknown), Charlotta Mellin, Uli Hacksell, Nils‐Erik Andén	8
20	Acetylene compounds of potential pharmacological value. XXV. N-(4-pyrrolidino-2-butynyl)-N-alkylcarboxamides. 1978 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·U Svensson, Uli Hacksell, Richard Dahlbom	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact